NCT03162120View on ClinicalTrials.gov

Comparison of Effectiveness of Ranolazine Plus Metoprolol Combination vs. FlecainidE pluS Metoprolol Combination in ATrial Fibrillation Recurrences FOllowing PhaRmacological or Electrical CardioverSion of AtRial Fibrillation

PHASE2/PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

September 1, 2018

Primary Completion Date

December 1, 2018

Study Completion Date

December 1, 2018

Conditions
Atrial FibrillationRecurrence
Interventions
DRUG

Ranolazine plus Metoprolol Combination

Ranolazine plus Metoprolol Combination in ATrial Fibrillation Recurrences FOllowing PhaRmacological or Electrical CardioverSion of AtRial Fibrillation

DRUG

FlecainidE pluS Metoprolol Combination

FlecainidE pluS Metoprolol Combination in ATrial Fibrillation Recurrences FOllowing PhaRmacological or Electrical CardioverSion of AtRial Fibrillation

Sponsors
All Listed Sponsors
lead

Elpen Pharmaceutical Co. Inc.

INDUSTRY